| | | | | | | |
 | JOHNSON & JOHNSON | 0.38% | -1.98% | -6.29% | -4.18% | 11.20% | 432 802 |
 | ELI LILLY AND COMPANY | -3.46% | -2.05% | -9.61% | 31.84% | 136.82% | 314 224 |
 | NOVO NORDISK A/S | 3.07% | -3.53% | -0.44% | 33.32% | 125.63% | 300 394 |
 | ROCHE HOLDING AG | 2.83% | -5.24% | -3.06% | -21.14% | -13.41% | 264 917 |
 | MERCK & CO., INC. | -3.29% | -3.19% | -6.75% | 26.16% | 21.09% | 262 312 |
 | ABBVIE INC. | -1.20% | -1.74% | -10.38% | 4.49% | 78.77% | 256 060 |
 | PFIZER, INC. | 0.84% | -2.44% | -13.47% | -17.68% | 19.07% | 248 894 |
 | ASTRAZENECA PLC | 2.19% | -3.70% | -6.63% | 22.05% | 40.48% | 194 954 |
 | NOVARTIS AG | 1.20% | -5.35% | -5.25% | 0.74% | -13.40% | 182 178 |
 | BRISTOL-MYERS SQUIBB COMPANY | 2.16% | -2.65% | 1.14% | 12.30% | 15.60% | 161 524 |
 | AMGEN INC. | 0.05% | -3.28% | -6.13% | 7.69% | 14.11% | 131 647 |
 | SANOFI | -3.02% | -3.29% | -6.33% | -8.81% | -3.94% | 118 344 |
 | GILEAD SCIENCES, INC. | -3.11% | -2.67% | -5.20% | 23.66% | 28.78% | 102 083 |
 | GSK PLC | 0.42% | 1.58% | -0.29% | -30.50% | -36.32% | 70 685 |
 | BAYER AG | -0.11% | 1.36% | 17.41% | 5.60% | -22.61% | 61 012 |
| | | | | | | |
| Durchschnitt | -0.07% | -2.54% | -4.08% | 5.70% | 26.79% | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 0.04% | -2.86% | -5.67% | 7.48% | 38.95% | |